Cavitation Technologies, Inc. (CVAT) Form 8-K — Oct 13, 2026
Cavitation Technologies (CVAT) entered into a definitive tender offer agreement with BrightFlixx Finance (Luxembourg) S.A. under which BrightFlixx intends to commence a cash tender offer for all outstanding CVAT shares at an aggregate price of $35 million less outstanding liabilities, implying an initial estimated offer price of $0.106 per share on 323,820,459 shares outstanding. The CVAT offer is paired with a concurrent $7 million tender offer for Alchemy Beverages Inc., in which CVAT holds approximately 17% equity, and each offer is conditioned on the other's consummation, plus 90% minimum tender and CFIUS clearance.
Key figures
- Deal Value Usd
- 42000000
- Record date
- 45 business days after commencement
- Offer period
- 60 business days from commencement
- Cvat liabilities
- 738000
- Shares outstanding
- 323820459
- Alchemy equity stake
- approximately 17%
- Warrant shares issuable
- 31571784
- Minimum tender condition
- 90% of outstanding shares
- Shareholder review period
- at least 30 business days after final offer price announcement
- Private placement max shares
- 5000000
- Cvat aggregate purchase price
- $35 million in cash less outstanding liabilities
- Alchemy aggregate purchase price
- $7 million in cash less outstanding liabilities
- Convertible right shares issuable
- 1250000
- Initial estimated offer price per share
- 0.106
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.